DK0590150T3 - (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat - Google Patents

(-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat

Info

Publication number
DK0590150T3
DK0590150T3 DK92909279T DK92909279T DK0590150T3 DK 0590150 T3 DK0590150 T3 DK 0590150T3 DK 92909279 T DK92909279 T DK 92909279T DK 92909279 T DK92909279 T DK 92909279T DK 0590150 T3 DK0590150 T3 DK 0590150T3
Authority
DK
Denmark
Prior art keywords
azaspiro
oxa
decane
tartrate
methylene
Prior art date
Application number
DK92909279T
Other languages
English (en)
Inventor
Shin-Ichi - - Kasuga Tsukamoto
Takeru Sumitomojuutak Kohinata
Mitsuo - Kanbeeshinden I Fujii
Sakiko - Asahigaokama Tomizawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of DK0590150T3 publication Critical patent/DK0590150T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92909279T 1991-05-15 1992-04-27 (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat DK0590150T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13961991 1991-05-15
PCT/JP1992/000548 WO1992020683A1 (fr) 1991-05-15 1992-04-27 L-tartrate de (-)-(s)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decane

Publications (1)

Publication Number Publication Date
DK0590150T3 true DK0590150T3 (da) 1999-04-19

Family

ID=15249510

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92909279T DK0590150T3 (da) 1991-05-15 1992-04-27 (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat

Country Status (11)

Country Link
US (1) US5403931A (da)
EP (1) EP0590150B1 (da)
AT (1) ATE168114T1 (da)
AU (1) AU1666392A (da)
CA (1) CA2109117A1 (da)
DE (1) DE69226187T2 (da)
DK (1) DK0590150T3 (da)
ES (1) ES2118814T3 (da)
GR (1) GR3027686T3 (da)
RU (1) RU2057132C1 (da)
WO (1) WO1992020683A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100370697B1 (ko) * 1993-08-19 2003-06-11 머크 앤드 캄파니 인코포레이티드 4'-데옥시-4'-에피-메틸아미노에버멕틴B1a/B1b벤조산염의순수한결정성반수화물형태B,이의제조방법및이를함유하는해충방제용조성물
ES2368824T3 (es) * 1998-03-27 2011-11-22 Oregon Health & Science University Vitamina d y sus análogos en el tratamiento de tumores y otros desórdenes hiperproliferativos.
JP2003063964A (ja) * 2001-08-28 2003-03-05 Senju Pharmaceut Co Ltd ドライアイまたはドライアイを伴なう疾病の予防治療剤
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
JPWO2007013661A1 (ja) * 2005-07-26 2009-02-12 千寿製薬株式会社 眼科用経皮吸収型製剤
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
NZ594768A (en) * 2009-01-26 2013-02-22 Israel Inst Biolog Res Bicyclic heterocyclic spiro compounds
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074441T3 (es) * 1987-10-05 1995-09-16 Yamanouchi Pharma Co Ltd Compuestos espiro heterociclicos y su preparacion.
US5075317A (en) * 1989-06-21 1991-12-24 Fisons Corporation Spirofurane derivatives

Also Published As

Publication number Publication date
GR3027686T3 (en) 1998-11-30
EP0590150B1 (en) 1998-07-08
CA2109117A1 (en) 1992-11-16
WO1992020683A1 (fr) 1992-11-26
EP0590150A1 (en) 1994-04-06
RU2057132C1 (ru) 1996-03-27
ES2118814T3 (es) 1998-10-01
AU1666392A (en) 1992-12-30
EP0590150A4 (en) 1994-06-29
DE69226187D1 (de) 1998-08-13
US5403931A (en) 1995-04-04
ATE168114T1 (de) 1998-07-15
DE69226187T2 (de) 1998-10-22

Similar Documents

Publication Publication Date Title
DK0590150T3 (da) (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat
PT91553A (pt) Processo de preparacao de uma composicao contendo morfina
FI942504A0 (fi) N,N'-diasetyylikystiinin orgaanisia suoloja
NO2002009I2 (no) Tiotropium
ATE50493T1 (de) Ibuprofen enthaltendes arzneimittel.
GR3020717T3 (en) Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
DK232989A (da) Antiviralt praeparat
FI911763A7 (fi) N5-metyyli-5,6,7,8-tetrahydrofoolihapon ammoniumsuolat
RU93058306A (ru) Моногидрат l-тартрата(-)-(s)-2,8-диметил-3-метилен-1-окса-8-азаспиро-(4,5)-декана
DE69002697D1 (de) Carboplatinzusammensetzung.
ATE140703T1 (de) Diaminsalze von clavulansäure
NO179504C (no) Legemiddel i form av en tablett inneholdende diritromycin
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
FR2649116B1 (fr) Composition organopolysiloxane monocomposante a stabilite au stockage amelioree
DE3681856D1 (de) Pharmazeutische 2-oxopyrrolidinverbindungen, ihre salze und ihre herstellung.
ITVE910013A0 (it) Progetto di catamarano da competizione formula o.p.1. a stabilita' idrodinamica indotta
ATE96025T1 (de) Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
ATE104986T1 (de) Aminsalze von 1,4,2-oxazaphospholidin-2-alkoxy-2oxid-4-essigs|uren.
PL298827A1 (en) Novel enantiomers derivatives of (s)-2-amino(3,4-dichlorobenzyl) propanol-1
DE58908028D1 (de) Als Fotodetektor verwendbare Bipolartransistorstruktur.
ATE69948T1 (de) Antiperspiranten mit alpha-2-adrenergener aminaktivitaet.